Survey - MBL-AR & Environmental & intrinsic factorsMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Beyond allergens How do environmental and intrinsic factors shape AR in Real world ENT practice1. Approximately what proportion of your AR patients report symptom triggers beyond classical allergens? More than 75% 50–75% 25–50% Less than 25%2. Which environmental factor most commonly aggravates AR in your practice? Air pollution Seasonal/weather changes Occupational exposure Tobacco smoke/passive smoking3. Which intrinsic factor most commonly contributes to persistent or difficult-to-control AR? Chronic rhinosinusitis Stress and poor sleep Obesity/metabolic disorders Deviated nasal septum/nasal structural abnormalities4. In your opinion, how significantly does psychological stress influence AR symptom severity? Significant contributor Moderate contributor Minor contributor No significant role5. Which co-existing condition most frequently complicates AR management? Asthma Chronic rhinosinusitis Gastroesophageal/Laryngopharyngeal reflux Sleep disorders6. Which patient characteristic is most commonly associated with recurrent AR exacerbations? Poor sleep quality Obesity Smoking/tobacco exposure Multiple co-existing triggers7. How often do you routinely assess lifestyle and intrinsic factors while evaluating AR patients? Always Often Sometimes Rarely8. What is the biggest challenge in managing AR influenced by multiple environmental and intrinsic factors? Identifying the predominant trigger Persistent symptom recurrence Poor patient adherence Continuous exposure to multiple triggers9. When managing mixed rhinitis (allergic + non-allergic components), which intrinsic factor is the strongest indicator that a purely anti-allergic regimen (e.g., systemic antihistamines alone) will fail? Predominant neurogenic symptoms (e.g., prominent watery rhinorrhea triggered by temperature/food) Severe underlying structural obstruction High autonomic tone / neurovascular instability Co-existing rhinosinusitis or mucosal hyperreactivity without clear IgE pathway involvement10. Which non-pharmacological intervention do you most frequently recommend? Allergen & pollution avoidance Nasal saline irrigation Lifestyle modification (sleep/stress/exercise) Combination of all these measures11. Which treatment goal do you prioritize in patients with multiple AR triggers? Rapid symptom relief Long-term inflammatory control Prevention of recurrence Improvement in quality of life12. When AR symptoms remain uncontrolled despite antihistamine therapy, what is your preferred next step? Add a Leukotriene Receptor Antagonist (Montelukast) Switch to Intranasal Corticosteroid ± Antihistamine spray Change to another second-generation antihistamine Evaluate for co-existing triggers/comorbidities before modifying therapy13. In which clinical scenario do you most commonly consider a Montelukast-based combination (with Levocetirizine, Fexofenadine, or Bilastine)? Persistent AR despite antihistamine monotherapy AR with asthma/exercise-induced bronchospasm Air pollution-triggered persistent AR Patients with frequent recurrent symptoms affecting quality of life I have read and agree to the Terms and Conditions .Submit Form